Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.
This article is from
The Cancer Letter
archive.
Vol. 32 No. 22 | June 9, 2006
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005
March 30, 2012
TCL Archive
NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues
February 12, 1993
TCL Archive
Cancer Mortality Increase Of 5.2% Now 28% Or Less
January 30, 1976
TCL Archive
NSABP Researcher Committed Misconduct, NIH Investigation Finds
March 18, 1994
TCL Archive
DFCI Puts The Cancer Letter On Its Intranet For Employees.
February 11, 2000
TCL Archive
ASCO Guidelines On CSFs Call For Use In Fewer Patients
December 2, 1994